Table 2.
Classification | Total population in cohort | No. of classified participants in cohort | Prevalence per 1,000 persons (95% CI) |
---|---|---|---|
Hyperuricemia | |||
Overall | 172,970 | 8,790 | 50.82 (49.79–51.86) |
Male | 58,981 | 7,859 | 133.25 (130.53–136.01) |
Female | 113,989 | 931 | 8.17 (7.66–8.71) |
Age, yr | |||
40–49 | 63,651 | 2,911 | 45.73 (44.14–47.38) |
50–59 | 66,618 | 3,150 | 47.28 (45.70–48.92) |
60–69 | 39,090 | 2,422 | 61.96 (59.61–64.39) |
70–79 | 3,611 | 307 | 85.02 (76.36–94.56) |
Hypouricemia | |||
Overall | 172,970 | 720 | 4.16 (3.87–4.48) |
Male | 58,981 | 65 | 1.10 (0.86–1.40) |
Female | 113,989 | 655 | 5.75 (5.32–6.20) |
Age, yr | |||
40–49 | 63,651 | 350 | 5.50 (4.95–6.10) |
50–59 | 66,618 | 227 | 3.41 (2.99–3.88) |
60–69 | 39,090 | 127 | 3.25 (2.73–3.86) |
70–79 | 3,611 | 16 | 4.43 (2.73–7.19) |
CI, confidence interval.